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A dysregulation of the redox homoeostasis has been
reported in various neoplastic disorders. Malondial-
dehyde/4-hydroxy-2,3-nonenal (MDA/HNE) and pro-
tein carbonyl groups represent in vivo indexes of
lipid peroxidation and protein oxidation, respec-
tively, suitable to investigate radical-mediated phy-
sio-pathological conditions.
We evaluated MDA/HNE and protein carbonyl groups
in sera of untreated Hodgkin’s lymphoma (HL)
patients in advanced disease stages, in order to
quantify the oxidative stress.
HL patients displayed significantly higher levels of
both MDA/HNE and protein carbonyl groups as
compared with healthy controls.
This is the first evidence that a strong increase in HL
is one of the most common haematological malig-
nancies, representing approximately 30% of all lym-
phomas in the circulating protein carbonyl content
in HL. These findings may contribute to a better
definition of the redox homoeostasis dysregulation
in HL.
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Hodgkin’s lymphoma (HL) represents approximately
30% of all malignant lymphomas; despite the recent
treatment success rate, the pathogenesis of HL is still
largely unknown.
Lipid peroxidation is a well-established mechanism
of cellular injury in both plants and animals. This
process, leading to the production of lipid peroxides
and their by-products, and ultimately the loss of
membrane function and integrity, is widely accepted
to be involved in the pathogenesis of several human
diseases.
Malondialdehyde (MDA) and 4-hydroxy-2,3-none-
nal (HNE) are end-products derived from peroxida-
tion of polyunsaturated fatty acids and related esters.
In contrast to free radicals, aldehydes are relatively
stable and therefore able to diffuse within or out of
the cell and to attack targets distant from the site of
original free-radical-initiated events. These aldehydic
molecules are considered ultimate mediators of toxic
effects elicited by oxidative stress occurring in
biological materials.
1
Measurement of MDA levels in plasma or serum
provides a suitable in vivo index of lipid peroxida-
tion and represents a non-invasive biomarker of
oxidative stress often clinically employed to investi-
gate radical-mediated physiological and pathological
conditions.
1
The action of reactive oxygen species on proteins
has been widely demonstrated to increase the
formation of carbonyl groups.
2 Moreover, carbonyl
stress may be due to the damaging effect of various
monodicarbonyls (such as MDA and HNE) and of
hypochlorous acid (whose production is catalysed by
myeloperoxidase in neutrophils) on proteins. How-
ever, in contrast to lipid peroxidation, protein oxida-
tion does not have the features of chain reactions.
Also the level of carbonyl groups in circulating
proteins is considered a useful marker of oxidative
stress, which may have some advantages in compar-
ison with the measurement of other parameters; in
fact, these oxidation products are formed relatively
early and are more stable.
In this study, we analysed the serum levels of
MDA/HNE and of protein carbonyl groups as para-
meters of lipid peroxidation and protein oxidation,
respectively, in order to quantify the oxidative stress
in untreated HL patients in advanced disease stages.
Fifteen previously untreated HL patients in III/IV
disease stages (four males and 11 females) with a
median age of 29 years (range, 19/65 years) entered
this study. Sera from 20 sex-matched and age-
matched normal subjects were also included in this
study as controls.
Sera were obtained from peripheral blood allowed
to clot at room temperature for 2 h, separated by
centrifugation at 200 /g for 15 min in a 4235 A
centrifuge (ALC Int. S.r.L., Milan, Italy), and stored at
 /808C until used.
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381Serum MDA/HNE levels were measured by means
of a colorimetric assay specific for MDA and carried
out using a commercially available kit (Calbiochem-
Novabiochem Corporation, La Jolla, CA, USA). This
method employs a chromogenic reagent, which
reacts with MDA/HNE at 458C, yielding a stable
chromophore with maximal absorbance at 586 nm.
The serum content of protein carbonyl groups was
evaluated with use of the Levine method; briefly,
100 ml of serum was incubated with 100 ml of a 20 mM
2,4-dinitro-phenylhydrazine solution for 60 min.
Then the proteins were precipitated from the solution
with the use of 20% trichloroacetate; the protein
pellet was washed three times with ethanol and ethyl
acetate and resuspended in 1 ml of 6 M guanidine at
378C for 15 min. The carbonyl content was deter-
mined from the absorbance at 366 nm (molar
absorption coefficient, 22,000 M
1/cm).
All statistical calculations were performed using the
statistical package SPSS for Windows (release 11.5,
2002 software; SPSS UK, Woking, UK). The non-
parametric Mann/Whitney U-test was employed to
test the differences between two groups. Data were
expressed as the mean9 /standard deviation. pB /0.05
was considered significant.
MDA/HNE serum levels were significantly higher
in HL patients as compared with controls (Fig. 1A)
(64.629 /26.81 nmol/ml versus 14.889 /1.81 nmol/ml,
pB /0.0001). Similarly, the serum content of protein
carbonyl groups was significantly more elevated in
HL patients than in normal subjects (44.219 /18.71
nmol/ml versus 25.379 /7.35 nmol/ml, pB /0.001)
(Fig. 1B).
It is well known that oxidative stress may be
associated not only with initiation, but also with
promotion and progression in the multistage carci-
nogenesis model.
In fact, the abnormal production of cellular oxi-
dants or the imbalance of the antioxidant control
systems have been linked to mutation (induced by
oxidant-induced DNA damage), as well as modifica-
tion of gene expression. Moreover, several signal
transduction pathways, such as activator protein-1
and nuclear factor-kB, are known to be activated by
reactive oxygen species, and they lead to the
transcription of genes involved in cell growth reg-
ulatory pathways.
3
With regard to MDA/HNE serum levels, our results
are in agreement with those of Guven et al., showing
significantly higher MDA concentrations in sera of HL
patients compared with healthy donors.
4 Moreover, a
high MDA concentration has been shown to be
associated with a dysregulation of antioxidant system
(i.e. low levels of selenium, zinc and glutathione
peroxidase activity in HL).
4
High levels of protein carbonyl groups have been
observed in several diseases, such as Alzheimer’s
disease, rheumatoid arthritis, diabetes, sepsis, chronic
renal failure, and in some malignancies.
To our knowledge, data on blood protein carbonyl
groups in HL were not currently available. Here we
show significantly higher circulating protein carbonyl
groups in HL patients, suggesting that HL patients
suffer from oxidative stress strictly affecting proteins.
Although it is rather out of the question to unravel
the issue of whether oxidative stress, in particular
protein oxidation, represents one of the causes or a
consequence of HL development, several models of
experimental tumourigenesis have shown that ele-
vated levels of protein carbonyl groups are early
targets of carcinogenesis.
In conclusion, we have herein confirmed the
involvement of lipid peroxidation and provided the
first evidence of a strong increase in circulating
protein carbonyl groups in HL patients. Consistent
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FIG. 1. Serum levels of (A) MDA/HNE and (B) protein
carbonyl groups detected in normal subjects (NS) and
patients affected by HL.
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5 measured a
higher level of protein carbonylation in platelets from
HL than in those from controls. Our data may
contribute to a better definition of the redox homo-
eostasis dysregulation in HL and suggest that anti-
oxidants may be considered a support therapy for
this disease.
References
1. Meagher EA, FitzGerald GA. Indeces of lipid peroxidation in vivo:
strenghts and limitation. Free Radic Biol Med 2000; 28: 1745/1750.
2. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein
carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;
329:2 3/38.
3. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis.
Annu Rev Pharmacol Toxicol 2004; 44: 239/267.
4. Guven M, Ozturk B, Sayal A, Ozet A. Lipid peroxidation and antioxidant
system in the blood of patients with Hodgkin’s disease. Clin Biochem
2000; 33: 209/212.
5. Goswami K, Koner BC. Level of sialic acid residues in platelet proteins in
diabetes, aging and Hodgkin’s lymphoma: a potential role of free radicals
in desialylation. Biochem Biophys Res Commun 2002; 297:5 0 2/505.
Received 11 August 2004
Accepted 17 August 2004
Oxidative stress in Hodgkin’s lymphoma
Mediators of Inflammation Vol 13  2004 383